Back to today’s briefing

Story perspectives

2025 Influenza Pipeline Report Reveals Key Therapies and Trials

10/18/2025

47 3 Full Breakdown

Summary

Story summary

The Influenza Pipeline Report 2025 analyzes emerging therapies and trials for influenza and details more than 120 active companies, including Moderna and Pfizer.
The report classifies therapies by development stage and route of administration.
Eurofarma conducted a phase 3 trial of a flu and cold treatment.
Influenza remains a significant health concern, causing thousands of deaths annually per the Centers for Disease Control and Prevention (CDC).

1 of 1

Story summary

The Influenza Pipeline Report 2025 analyzes emerging therapies and trials for influenza and details more than 120 active companies, including Moderna and Pfizer.
The report classifies therapies by development stage and route of administration.
Eurofarma conducted a phase 3 trial of a flu and cold treatment.
Influenza remains a significant health concern, causing thousands of deaths annually per the Centers for Disease Control and Prevention (CDC).